VIDAL Sentinel, real-time monitoring of prescription risks

Data feed from the prescription software, biological analysis results and other patient variables (age, weight, sex);

Data analysis according to business rules that combine the notions of patient at risk and drug at risk;

Assignment of a systematically justified risk score for each file in order to organize pharmaceutical prioritization;

Automatic recalculation whenever one of the parameters changes (new prescription, new biological result).

Based on publications and risk assessment (mainly from the French Society of Clinical Pharmacy), the VIDAL scientific committee and the user community;

Can be used directly "out of the box" with a body of validated rules;

Relevant regardless of the evolution of the institution's booklet or the market (new commercializations) by relying on the drug's properties managed in the VIDAL database;

Locally weighted in order to adapt to the specificities of an establishment;

Integrating the notion of obsolescence of clinical data.